High-Throughput Screening and Fragment-Based Approach for Flavivirus Antiviral Discovery
Microorganisms · 06.11.2026 · 14 (11) · 2556
DOI: 10.3390/microorganisms14112556 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microorganisms, online erschienen am 06.11.2026. Verfasst von Bruna Campestrini Casarin und 3 weiteren Autor:innen. Die Arbeit nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: São Paulo Research Foundation.
Abstract (Originalsprache)
Members of the genus Orthoflavivirus pose severe global health threats with substantial morbidity and mortality. No specific antiviral therapies are currently approved, leaving clinical management limited to supportive care. The development of broad-spectrum pan-flavivirus antivirals requires targeting highly conserved structural and non-structural proteins essential for viral replication. High-throughput screening (HTS) and fragment-based drug discovery (FBDD) represent the primary complementary methodologies for initial hit identification. This review critically compares HTS and FBDD workflows, hit rates, target strategies, and overall efficacy in pan-flavivirus drug discovery.
Förderung
- São Paulo Research Foundation
Zitieren
APA
Casarin, B. C., Ellinger, B., Nascimento, A. S., & Wrenger, C. (2026). High-Throughput Screening and Fragment-Based Approach for Flavivirus Antiviral Discovery. Microorganisms, 14(11), 2556. https://doi.org/10.3390/microorganisms14112556
Vancouver
Casarin BC, Ellinger B, Nascimento AS, Wrenger C. High-Throughput Screening and Fragment-Based Approach for Flavivirus Antiviral Discovery. Microorganisms. 2026;14(11):2556. doi:10.3390/microorganisms14112556
BibTeX
@article{Casarin2026,
author = {Casarin, Bruna Campestrini and Ellinger, Bernhard and Nascimento, Alessandro Silva and Wrenger, Carsten},
title = {High-Throughput Screening and Fragment-Based Approach for Flavivirus Antiviral Discovery},
journal = {Microorganisms},
year = {2026},
volume = {14},
number = {11},
pages = {2556},
doi = {10.3390/microorganisms14112556}
}
EUVIMED